Evolution and Validation 0f Practice Standards, Training, and Professional Development
Review table of contents of high-impact journals in critical care (e-mail or rich site summary
Care Surgery, Journal of Critical Care).
ii.
Topic alerts (e-mail or RSS) for critical care articles from high-impact multispecialty journals
iii.
iv.
Use of saved search strategies with automatic e-mail alerts on a scheduled interval (e.g.,
PubMed, PubCrawler, Ovid Medline)
Subscribe to a medical information alert service with high and transparent standards for
validity, relevance, and contextual interpretation of the data (e.g., Essential Evidence Plus, FPIN
[Family Physicians Inquiries Network] Clinical Inquiries, BMJ Clinical Evidence, Cochrane
for Clinicians).
vi.
Scan review journals relevant to critical care (e.g., Critical Care Clinics).
vii.
Identify high-quality, relevant, and contemporary clinical practice guidelines for critical care
therapeutics (e.g., National Guideline Clearinghouse, PubMed Clinical Queries, MD Consult).
viii.
Use up-to-date systematic reviews (e.g., Cochrane Database of Systematic Reviews, Agency for
Healthcare Research and Quality [AHRQ] Evidence-Based Practice Center Evidence-Based
Reports).
ix.
Selective use of other resources (e.g., evidence-based summaries such as Bandolier, Clinical
Evidence), critically appraised topics, point-of-care review services (e.g., UpToDate, Medscape),
database)
| d. | The tools and resources available for staying current with the literature is a rapidly evolving, dynamic |
|---|
market. The individual pharmacist will need to stay current to maximize use of the literature and
will need to adapt his or her strategy over time.
Discussion and debate with colleagues, mentors, and other content experts
Therapeutic dilemmas
Complex cases
Primary literature
| d. | Guidelines |
|---|
Journal clubs/clinical conferences
Interdisciplinary, patient care rounds β Daily interactive discussions of diagnostics, disease states,
therapeutics, monitoring, technology in the ICU, ethics, communication with patients and families, etc.
Guideline and protocol development for the ICU
Translation of evidence to best practices
Benchmarking with peer institutions
Consensus building
| d. | Project management β Implementation and measurement of outcomes |
|---|
Point-of-care learning
Refers to day-to-day learning opportunities
Uncommon disease state or unexpected adverse drug reaction prompts reading and learning.
Complex drug information questions from colleagues